Mexico’s pharma industry eyes growth with 13B pesos promised for drug development and manufacturing

Mexico’s pharma industry eyes growth with 13B pesos promised for drug development and manufacturing

Four Mexican pharmaceutical companies announced investment plans totaling more than 13 billion pesos at President Claudia Sheinbaum’s Thursday morning press conference. Sheinbaum said at the start of the press conference that the four companies — Kener, Genbio, Neolpharma and Neolsym — had “decided to join Plan México,” the federal government’s ambitious economic initiative that seeks to spur investment and make Mexico more self-sufficient, amon…